Asset Allocation & Management Company’s Ford F Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$362K Hold
30,000
– – 0.11% 52
2026
Q2
$417K Hold
30,000
– – 0.14% 48
2026
Q1
$346K Hold
30,000
– – 0.13% 67
2025
Q4
$394K Hold
30,000
– – 0.16% 56
2025
Q3
$359K Hold
30,000
– – 0.15% 58
2025
Q2
$326K Hold
30,000
– – 0.15% 69
2025
Q1
$301K Hold
30,000
– – 0.15% 67
2024
Q4
$297K Sell
30,000
-20,000
-40% -$213K 0.16% 65
2024
Q3
$528K Hold
50,000
– – 0.33% 31
2024
Q2
$627K Hold
50,000
– – 0.41% 30
2024
Q1
$664K Hold
50,000
– – 0.43% 31
2023
Q4
$610K Hold
50,000
– – 0.41% 32
2023
Q3
$621K Hold
50,000
– – 0.37% 34
2023
Q2
$757K Hold
50,000
– – 0.3% 34
2023
Q1
$630K Hold
50,000
– – 0.25% 59
2022
Q4
$582K Hold
50,000
– – 0.23% 66
2022
Q3
$560K Hold
50,000
– – 0.23% 67
2022
Q2
$557K Hold
50,000
– – 0.23% 68
2022
Q1
$846K Buy
+50,000
New +$951K 0.3% 73

Other funds holding F

Asset Allocation & Management Company's F Position: Q3 2026 in Review

Asset Allocation & Management Company held its Ford (F) position steady in Q3 2026 at 30,000 shares worth $362K. The position accounts for 0.11% of the portfolio, ranked #52.

Asset Allocation & Management Company first reported a position in F in Q1 2022 and has held it in 19 quarters since. The position peaked at $846K in Q1 2022. 1,760 funds tracked by Wall St. Rank hold F as of Q3 2026.

  • Asset Allocation & Management Company held 30,000 shares of Ford worth $362K as of Q3 2026.
  • Asset Allocation & Management Company left its Ford share count unchanged in Q3 2026.
  • Ford made up 0.11% of Asset Allocation & Management Company's portfolio in Q3 2026, its #52 holding.
  • Asset Allocation & Management Company first reported a position in Ford in Q1 2022 and has held it in 19 quarters since.
  • Asset Allocation & Management Company's Ford position peaked at $846K in Q1 2022.
  • 1,760 funds tracked by Wall St. Rank held Ford as of Q3 2026.

Based on Asset Allocation & Management Company's 13F filing for Q3 2026, filed 13 Oct 2026.